All Episodes
Flot.bio x Philip Hemme — 61 episodes
Billionaire wild bets on Consumer Biotech, GLP-1s, and psychedelics | Christian Angermayer | E61
ImCheck ex-CEO on ASCO Oncology Trends, $1.2B Exit and French Biotech | Pierre d’Epenoux | E60
CEO Jean-François Brepson on Scaling a CRO, and Selling to Charles River | E59 [Sponsored]
Ex-CEO of Incyte Hervé Hoppenot on 10x Growth, Biotech Cycles, and Breaking Bureaucracy | E58
Christoph Lengauer, Curie.Bio | Biotech Founders, Venture Capital | E57
Sander Slootweg, Forbion 🇳🇱 | European Biotech Investment, Venture Capital | E56
Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]
António Portela, Bial 🇵🇹 | Parkinson’s, Family-Owned Biotech | E54
Claus Crone Fuglsang, Novonesis 🇩🇰 | Biosolutions, Industrial biotech, Synbio | E53
Sten R. Sörensen, Cereno Scientific 🇸🇪 | Drug Repurposing, Retail Investors | E52 [Sponsored]
Fredrik Tiberg, Camurus 🇸🇪 | Opioid Crisis, Long-Acting Injections | E51
Alessandro Riva, Transgene | Cancer Vaccines, Oncolytic Viruses | E50
Pascal Touchon 🇫🇷 | Cell Therapy, Jeito, Kymriah | E49
Werner Lanthaler 🇦🇹 | Biopharma AI, CDMO, Antibody Optimization | E48
Thomas Lingelbach, Valneva | Vaccines, Lyme Disease | E47
Marc de Garidel, Abivax 🇫🇷 | Ulcerative Colitis, Inflammation | E46
Laurent Levy, Nanobiotix 🇫🇷 | Nanoparticles, Radiotherapy | E45
Gerrit Sitters, LUMICKS 🇳🇱 | CAR-T therapy, Single-Cell Analysis | E44 [Sponsored]
Fabrice Chouraqui, Pharming 🇳🇱 | Transgenic Rabbits, Rare Diseases | E43
Daniela Marino, CUTISS 🇨🇭 | Tissue Engineering, Skin Grafts | E42 [Sponsored]
Dragan Grabulovski, Araris 🇨🇭 | ADC Linkers, Replacing Chemotherapy | E41
Stefano Portolano, Azafaros 🇳🇱 🇨🇭 | Rare Diseases, Small Molecules | E40
Alex Zhavoronkov, Insilico Medicine | AI Drug Development, Longevity | E39
Robin Carr, Myricx Bio 🇬🇧 | New ADC Payloads, London Biotech Startups | E38
Aino Kalervo, TILT Biotherapeutics 🇫🇮 | Immunotherapy, Oncolytic Virus | E37 [Sponsored]
Renee Aguiar-Lucander, Hansa Biopharma 🇸🇪 | Immunology, Gene therapy | E36
Stephane Bancel, Moderna | mRNA Therapeutics, Boston Biotech Mafia, AI Biotech | E35
Chris Martin, Verona Pharma 🇬🇧 | Ohtuvayre, COPD, Execution | E34
Daniela Marino, CUTISS 🇨🇭 | Skin Tissue Therapeutics, TechBio | E33 [Sponsored]
Joris Pezzini, Alira Health | Hottest Biotech Insights | E32 [Sponsored]
Christophe Bourdon, LEO Pharma 🇩🇰 | Biopharma Turnaround | E31
Christoph Broja, EQT 🇩🇪🇳🇱 | #1 European Biotech VC, LSP Marriage, ADCs | E30
Philipp Baaske, NanoTemper 🇩🇪 | Bootstrapping in Biotech | E29 [Sponsored]
Mathias Uhlen 🇸🇪 | Entrepreneurial Scientist, 26 times | E28
Thomas Ybert, DNA Script 🇫🇷 | DNA Printing & Synthesis | E27
Gunilla Osswald, BioArctic 🇸🇪 | Leqembi, Alzheimer’s disease | E26
Sean Marett 🇩🇪 | BioNTech, Art of Dealmaking | E25
Lovisa Afzelius, Flagship Pioneering 🇸🇪 | Company building, AI | E24
Szabolcs Nagy, Turbine 🇭🇺 | AI in Biotech, Simulation | E23 [Sponsored]
Adrian Rawcliffe, Adaptimmune 🇬🇧 | Tecelra, TCR Cell Therapy, Solid Tumors | E22
Marina Udier, Nouscom 🇨🇭 | Cancer Vaccines, Neoantigens | E21
Harpreet Singh, Immatics 🇩🇪 | PRAME, TCR Based Therapeutics | E20
Dominik Schumacher, Tubulis 🇩🇪 | Founder-led ADC Biotech ⭐️ | E19
Otello Stampacchia, Omega Funds 🇮🇹 | M&A, Boston & Pasta | E18
Christina Takke, V-Bio Ventures 🇧🇪 | Wonder VC Woman | E17
Naveed Siddiqi, Novo Holdings 🇬🇧🇩🇰 | Sharp Macro View of EU Biotech | E16
Claudia Ulbrich, Cardior 🇩🇪 | Being the Founder of a Rare €1B Exit | E15
Bahija Jallal, Immunocore 🇬🇧 | Commercial, Diversity, and AI | E14
Edwin Moses | How to build large biotech platforms | E13
Jens Nielsen, BII | How to make translation of life science research work | E12
Sander van Deventer, VectorY & Forbion | Pioneering gene therapy | E11
Thomas Clozel, Owkin | What does AI Biotech really mean | E10
Marc de Garidel, Abivax | How to make two billion 💶 exits ("smoothly") | E09
Mike Ward | The Best and the Worst since the 80s in EU Biotech | E08
Agnete Fredriksen, Nykode | Being one of the top 50 women in 🇪🇺 bio | E07
Rodger Novak, CRISPR Tx | Bringing the first CRISPR drug to the market | E06
Johannes Fruehauf, BioLabs | Reinventing Incubators For Bio Startups | E05
Bernat Olle, Vedanta | Where is the Microbiome Industry Now | E04
Ingmar Hoerr, CureVac | Founding a $20B Biotech and Almost Dying as CEO | E03
Werner Lanthaler, Evotec | Leading AI in Biotech | E02
Antoine Papiernik, Sofinnova | €Billion Biotech Investing With Balance | E01